Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: Proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits
Source abstract
Abstract
Steroid-associated osteonecrosis (SAON) may lead to joint collapse and subsequent joint replacement. Poly lactic-co-glycolic acid/tricalcium phosphate (P/T) scaffold providing sustained release of icaritin (a metabolite of Epimedium-derived flavonoids) was investigated as a bone defect filler after surgical core-decompression (CD) to prevent femoral head collapse in a bipedal SAON animal model using emu (a large flightless bird). The underlying mechanism on SAON was evaluated using a well-established quadrupedal rabbit model. Fifteen emus were established with SAON, and CD was performed along the femoral neck for the efficacy study. In this CD bone defect, a P/T scaffold with icaritin (P/T/I group) or without icaritin (P/T group) was implanted while no scaffold implantation was used as a control. For the mechanistic study in rabbits, the effects of icaritin and composite scaffolds on bone mesenchymal stem cells (BMSCs) recruitment, osteogenesis, and anti-adipogenesis were evaluated. Our efficacy study showed that P/T/I group had the significantly lowest incidence of femoral head collapse, better preserved cartilage and mechanical properties supported by more new bone formation within the bone tunnel. For the mechanistic study, our in vitro tests suggested that icaritin enhanced the expression of osteogenesis related genes COL1α, osteocalcin, RUNX2, and BMP-2 while inhibited adipogenesis related genes C/EBP-ß, PPAR-γ, and aP2 of rabbit BMSCs. Both P/T and P/T/I scaffolds were demonstrated to recruit BMSCs both in vitro and in vivo but a higher expression of migration related gene VCAM1 was only found in P/T/I group in vitro. In conclusion, both efficacy and mechanistic studies show the potential of a bioactive composite porous P/T scaffold incorporating icaritin to enhance bone defect repair after surgical CD and prevent femoral head collapse in a bipedal SAON emu model.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone and Joint Diseases · Bone health and osteoporosis research · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (76)
Show source-provided references
1. Pathogenesis and natural history of osteonecrosis10.1053/sarh.2002.33724b ↗
2. Steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy10.1080/00313020600696231 ↗
3. Nontraumatic osteonecrosis of the femoral head: ten years later
4. Steroid induced osteonecrosis: an analysis of steroid dosing risk10.1016/j.autrev.2010.06.007 ↗
5. Epidemiology of nontraumatic osteonecrosis of the femoral head in Japan
6. Risk factors for avascular bone necrosis in systemic lupus erythematosus10.1093/rheumatology/37.8.895 ↗
7. National Center for Health Statistics · 2014
8. Nontraumatic necrosis of bone (Osteonecrosis)10.1056/NEJM199205283262206 ↗
9. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development10.1186/1749-799X-2-15 ↗
10. Impaired bone healing in rabbits with steroid-induced osteonecrosis10.1302/0301-620X.93B4.25442 ↗
11. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial10.1359/jbmr.070405 ↗
12. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis10.1007/s00198-011-1577-2 ↗
13. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner10.1016/j.bone.2008.10.035 ↗
14. Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis–an in vitro efficacy study10.1371/journal.pone.0041264 ↗
15. Printing and prototyping of tissues and scaffolds10.1126/science.1226340 ↗
16. Fabrication of a two-level tumor bone repair biomaterial based on a rapid prototyping technique10.1088/1758-5082/1/2/025003 ↗
17. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study10.1016/j.actbio.2012.04.030 ↗
18. Comparative study of PLGA/TCP scaffolds incorporated or coated with osteogenic growth factors for enhancement of bone regeneration
19. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study10.1016/S0140-6736(10)60668-X ↗
20. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues10.1002/jbm.b.30962 ↗
21. PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits10.1016/j.actbio.2013.01.024 ↗
22. Exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair10.1002/jor.22188 ↗
23. Steroid-associated hip joint collapse in bipedal emus10.1371/journal.pone.0076797 ↗
24. Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone10.1016/j.bone.2006.04.018 ↗
25. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin10.1088/1748-6041/5/5/054109 ↗
26. Evaluation of bone-tendon junction healing using water jet ultrasound indentation method10.1016/j.ultrasmedbio.2009.06.1093 ↗
27. Noncontact evaluation of articular cartilage degeneration using a novel ultrasound water jet indentation system10.1007/s10439-008-9602-0 ↗
28. Impaired bone healing in rabbits with steroid-induced osteonecrosis
29. Promotion of bone repair by implantation of cryopreserved bone marrow-derived mononuclear cells in a rabbit model of steroid-associated osteonecrosis10.1002/art.34525 ↗
30. A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models10.1016/0021-9290(95)80008-5 ↗
31. Elastic modulus and strength of emu cortical bone
32. The elastic properties of trabecular and cortical bone tissues are similar: results from two microscopic measurement techniques10.1016/S0021-9290(98)00177-8 ↗
33. The elastic modulus for bone10.1016/0021-9290(74)90018-9 ↗
34. Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation10.1016/S0142-9612(97)00073-2 ↗
35. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans10.1359/jbmr.080805 ↗
36. Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images10.1016/S8756-3282(02)00736-6 ↗
37. Microspectrophotometric quantitation of glycosaminoglycans in articular cartilage sections stained with Safranin O10.1007/BF00501401 ↗
38. Partial patellectomy induces a decrease in the proteoglycan content in the remaining patellar articular cartilage. An experimental study in rabbits
39. Osteogenesis induced by extracorporeal shockwave in treatment of delayed osteotendinous junction healing10.1002/jor.20948 ↗
40. Changes in dentin appositional rates during pregnancy and lactation in rats10.1177/00220345850640080701 ↗
41. Endothelial progenitor cell and mesenchymal stem cell isolation, characterization, viral transduction10.1007/978-1-59745-571-8_12 ↗
42. Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis-an in vitro efficacy study10.1371/journal.pone.0041264 ↗
43. Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: a rat patellar tendon model10.1080/000164700317381234 ↗
44. Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles10.1002/chem.200901548 ↗
45. Low-intensity pulsed ultrasound increases cellular uptake of superparamagnetic iron oxide nanomaterial: results from human osteosarcoma cell line U2OS10.1002/jmri.22173 ↗
46. Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone10.1016/j.bone.2006.04.018 ↗
47. Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides10.1371/journal.pone.0017001 ↗
48. ARCO Committee on Terminology and Staging.The ARCO perspective for reaching one uniform staging system of osteonecrosis
49. The role of MR imaging in staging femoral head osteonecrosis10.1016/j.ejrad.2007.03.029 ↗
50. Exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair10.1002/jor.22188 ↗
51. Articular cartilage changes in avascular necrosis: an arthroscopic evaluation10.1097/00003086-200301000-00011 ↗
52. Corticosteroids alter the differentiated phenotype of articular chondrocytes10.1016/S0736-0266(00)00060-7 ↗
53. Increased chondrocyte death after steroid and local anesthetic combination10.1007/s11999-010-1443-0 ↗
54. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development10.1186/1749-799X-2-15 ↗
55. Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis10.1074/jbc.M611435200 ↗
56. Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis10.1007/s12016-010-8217-z ↗
57. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow10.2106/00004623-199707000-00012 ↗
58. Osteogenic gene expression decreases in stromal cells of patients with osteonecrosis10.1097/01.blo.0000238869.99980.b2 ↗
59. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation10.3892/ijmm.2014.1821 ↗
60. BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription10.1074/jbc.M111.253187 ↗
61. Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis–an in vitro efficacy study10.1371/journal.pone.0041264 ↗
62. The effect of core decompression on local expression of BMP-2, PPAR-γ and bone regeneration in the steroid-induced femoral head osteonecrosis10.1186/1471-2474-13-142 ↗
63. Regulating adipogenesis10.1074/jbc.272.9.5367 ↗
64. Transcriptional control of adipogenesis10.1016/S0955-0674(98)80138-5 ↗
65. Regulation of PPARgamma activity during adipogenesis10.1038/sj.ijo.0802907 ↗
66. Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line10.1194/jlr.M300084-JLR200 ↗
67. PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis10.1038/nrendo.2010.155 ↗
68. The stem cell movement10.1161/CIRCRESAHA.108.175158 ↗
69. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms
70. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells10.1182/blood-2006-05-025098 ↗
71. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells10.1016/j.yjmcc.2008.03.010 ↗
72. Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization10.1159/000342921 ↗
73. Emu model of full-range femoral head osteonecrosis induced focally by an alternating freezing and heating insult
74. A new animal model of femoral head osteonecrosis: one that progresses to human-like mechanical failure10.1016/S0736-0266(01)00108-5 ↗
75. The rational use of animal models in the evaluation of novel bone regenerative therapies10.1016/j.bone.2014.07.010 ↗
76. Use of animal models in musculoskeletal research